Monday, September 30, 2019
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX: $AVCN.TO), (OTCQB: $DIGP), (CSE: $HARV.C) (OTCQX: $HRVSF), (CSE: $TGIF.C) (OTCQX: $TGIFF)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX: $AVCN.TO), (OTCQB: $DIGP), (CSE: $HARV.C) (OTCQX: $HRVSF), (CSE: $TGIF.C) (OTCQX: $TGIFF)
Delta, Kelowna, BC –September 30 , 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts
In today’s podcast we look at a few early announcements.
But first, the Canadian Health Food Association (CHFA) released its submission to Health Canada's consultation on Potential Market for Cannabis Health Products (CHPs) that Would not Require Practitioner Oversight. Current cannabis regulations in Canada prohibit the sale of CBD outside of provincially regulated recreational cannabis retailers, or without a physician's note.
"While CHFA is pleased to see Health Canada initiate the conversation on addressing this major gap in the cannabis regulatory regime, we are disappointed in, and disagree with, a significant proportion of the key parameters outlined within Health Canada's consultation document," said Helen Long, President of CHFA.
"Health Canada has proposed a pathway that would maintain the status quo, keeping the production and sale of all "cannabis health products" under the Cannabis Act and its Regulations. As a naturally occurring substance, CBD should be regulated as a natural health product. We doubt that the proposed framework will allow businesses to fulfill the large consumer demand for CBD health products, nor will it displace the growing illicit market for CBD health products."
CHFA suggests a different path forward. This pathway would require targeted amendments to the Industrial Hemp Regulations (IHR), the Natural Health Products Regulations (NHPR) and the Prescription Drug List (PDL) to permit ingredients from industrial hemp to be extracted, produced and sold outside of the scope of the Cannabis Regulations. These ingredients would then be permitted for use in natural health products (NHPs) under the NHPR. "Rather than duplicate Canada's existing, world class NHP regulatory system, it would be better for Canadian consumers and Canadian industry to permit hemp-derived CBD in NHPs," explained Long.
"Canadians are already using CBD for a variety of health-related purposes: whether it's pain relief, helping them to sleep, or calming their stress," added Long. "The problem is access to legal CBD health products is limited. It doesn't make sense for Canadians to access CBD for their health through recreational channels, and they should be able to go to their local natural health product retailer to purchase an NHP that contains CBD."
The proposed alternative by CHFA will also support rapid innovation and growth within Canada's natural health product and agricultural hemp industries by removing barriers to production, processing and marketing of CBD derived from hemp. "The hemp sector is projecting significant growth by 2023 – that is upwards of $1 billion in economic benefits," added Long. "However, a proportion of this economic growth is contingent upon an improved pathway to bring CBD health products to market – something that CHFA's solution accounts for."
In addition to the Health Canada consultation submission, CHFA recently launched a national campaign called "CBD is Natural" that calls upon industry participants and Canadian consumers to engage with their local candidates on this important issue.
"We launched CBD is Natural to mobilize Canadians to speak-up during the election and call on all parties to update Canada's regulations to permit the sale of CBD in NHPs – and clearly, our message was heard," said Long. "We applaud Elizabeth May and the Green Party of Canada for becoming the first party to formally recognize the importance of this issue and commit to solving the problem in their official platform by permitting hemp-derived CBD in NHPs. We now look to the other parties to do the same."
Avicanna Inc. (TSX: AVCN), a biopharmaceutical company focused on the development, manufacturing and commercialization of organic and sustainable plant-derived cannabinoid-based products, announced plans to build a new industrial scale 11,000 sq. ft (>1,000 square meter) cannabinoid extraction and final product manufacturing facility in a Colombian free trade zone near Santa Marta. This new facility is expected to provide for significant tax advantages and represents the third phase of the Company's extraction strategy, building on its existing subsidiaries' extraction and manufacturing operations in Colombia with current aggregate annual capacity of dried flower – post extraction and isolation – of approximately 100,000 kilograms.
The operation of the new facility will be conducted under a proposed new subsidiary, which will be 60% owned by the Company and 40% owned by Inmobiliaria Bondue S.A.S. The Company expects operations at the facility to commence in the second half of 2020.
The Company and Bondue have entered into a commercial lease agreement for space to house the facility, for an initial term of five years, located in one of Colombia's free trade zones, which provides for significant tax advantages for activities that are conducted on the property.
Contributing to expanding Avicanna's vertical integration strategy, the new facility will use cannabis sourced from Avicanna's other majority owned Colombian based subsidiaries, Sativa Nativa S.A.S and Santa Marta Golden Hemp S.A.S., which are situated in Santa Marta. The extracts (active pharmaceutical ingredients) and final products produced at the facility are expected to be distributed internationally with additional tax savings.
Aras Azadian, Avicanna's Chief Executive Officer, stated, "We near the final phase of our initial cultivation and extraction footprint and are analyzing and preparing for our future scale up with focus on efficiencies across all aspects of operations including CAPEX, OPEX, regulations and tax. This new facility's proposed contribution to our API business, which benefits from its location in a free trade zone, makes it a fine example of Avicanna's focus on efficiencies across all of its business units and our aim to ensure each unit, including the ones that are focused on cannabinoids as API's, are both efficient profit centers and are competitive in a commodifying global landscape."
Sativa Nativa and SMGH have licenses to cultivate, manufacture, extract and sell medicinal cannabis in Colombia. Sativa Nativa's cultivation facilities include 50,000 square feet of low tech green house (shade house) and 20,000 square feet of customized high tech greenhouse space. SMGH has applied for Good Agricultural and Collection Practices and organic certifications and operates cultivation facilities that include 200,000 square feet of low tech green house (shade house) space and 20,000 square feet of customized high tech greenhouse space. SMGH is currently expanding its green house operation by approximately 70,000 square feet, and Sativa Nativa is expanding its green house operation by approximately 50,000 square feet. The Company expects these expansion activities to be completed by the end of 2019.
In addition, through a joint venture with Sigma Analytical Services Inc., Avicanna is currently building a first cannabinoids-only, analytical laboratory and independent testing service in South America to meet Health Canada, European Pharmacopeia, US Pharmacopeia, and compliant to EU Good Manufacturing Practices ("GMP") standards. This laboratory will provide a variety of large licensed producers to small scale partner farmers with a comprehensive suite of cannabis specific testing, which will include pesticides, heavy metals, residual solvents, aflatoxins, microbial, genotyping, and cannabinoid and terpene profiling. With technical transfer currently underway, the completion and launch of the laboratory services is expected to occur early in the first quarter of 2020.
Digipath, Inc. (OTCQB: DIGP), announced that it has entered into a binding letter of intent for the acquisition of VSSL Enterprises Ltd., a British Columbia based cannabis genomics, plant sciences and consulting firm. The acquisition is expected to provide Digipath with a wealth of cannabis data, technology and intellectual property, including in excess of a thousand hemp and cannabis genotypes. The letter of intent provides for the acquisition of 100% of VSSL’s outstanding shares of capital stock for consideration consisting of six million shares of Digipath common stock and a cash payment of $200,000, and is subject to the execution of definitive agreements.
VSSL builds predictive tools for the cannabis industry. Whether it’s for a breeder, cultivator or processor, understanding the genetic basis of key traits such as yield, expression of secondary metabolites or disease resistance can provide a competitive advantage to its clients by allowing rapid decision making and process optimization. VSSL uses molecular and bioinformatics tools to deliver unique solutions suited to its customers’ diverse germplasm and business models.
Effective upon signing the letter of intent, VSSL Chief Executive Officer, Kyle Remenda was appointed to serve as Digipath’s Chief Executive officer. Todd Denkin, the former CEO, has resigned his positions with Digipath to pursue other opportunities. Under Mr. Denkin’s leadership, Digipath has become the leading cannabis testing laboratory in Las Vegas, a leader in data analysis and a recognized brand around the country. He will continue to consult with the Company through the end of 2019.
Mr. Remenda is a passionate advocate within the medical marijuana industry. Under Kyle’s leadership, VSSL has become a trusted source of technology and genotype technology and consulting. Before starting VSSL, Mr. Remenda worked in the medical marijuana industry with established legal grow operations in North America. He and the VSSL team bring a wealth of expertise in plant breeding, genetics and production craft.
“Kyle is the right person to lead the next phase in the evolution of Digipath, building on our outstanding pedigree in cannabis technology, vision and experience. With Kyle on board and combining with VSSL, Digipath can move into larger revenue opportunities,” stated Todd Denkin.
Harvest Health & Recreation, Inc. (CSE: HARV) (OTCQX: HRVSF), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., today announced the opening of Harvest of Venice, expanding their footprint in the California market. Harvest's best-in-class product offerings and exceptional store experience will now be available to the community of Venice, CA.
"Harvest has continued to grow our presence in the world's largest cannabis market, California, by creating retail destinations that bring high-quality products, local events and resources to the communities we join," said Harvest CEO Steve White. "Venice is a community with a rich and vibrant cannabis history and we are excited to bring our store experience to consumers in the market, introducing them to our best-in-class products and knowledgeable staff."
Harvest of Venice is located at 712 Lincoln Blvd and is open from 7am to 10pm seven days a week and features photography from Southern California photographers. Harvest is quickly expanding its presence in California with the recent openings of Harvest's Napa and Grover Beach locations, and upcoming opening of Harvest of Palm Springs. Harvest has also secured the right to retail licenses in a number of other California cities. Harvest of Venice will announce an upcoming community event slated for later this fall.
1933 Industries Inc. (CSE: TGIF) (OTCQX: TGIFF), a vertically integrated cannabis consumer packaged goods company, announced that it has commenced the flowering cycle of its cannabis plants in its new, purpose-built, indoor cultivation facility located in Las Vegas, Nevada.
Following the transfer of cannabis plants to the new facility in late August, the plants completed a vegetative stage for four weeks. Three rooms will begin the flowering cycle this week, lasting approximately eight weeks. The first harvest from the initial three rooms is expected in early December, with continued harvests thereafter every two weeks, all while new grow rooms are added in the facility for a total of 15 bloom rooms. The initial 26 strain varieties currently at the facility will be augmented with an additional 12 Cannabis Cup award-winning strains to sustain the Company's flower and concentrate production of branded AMA products and third party brands.
Mr. Tim Spencer, Director of Cultivation, said, "Our plants are performing very well in our state-of-the-art indoor facility and we are continuously learning and improving our processes. The facility is specifically built with integrated technology with high controls and automation to cultivate high-quality craft cannabis at scale with assured consistency and efficiency." He added, "The increased output will provide sufficient supply for the production of our AMA branded products as well as for our licensing partners such as Blonde™ Cannabis, OG DNA Genetics, Jack Herer, and PLUGplay."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Friday, September 27, 2019
Investorideas.com - Cannabis Stock News: Dixie Brands (CSE: DIXI.U) (OTC: DXBRF) and Herbal Enterprises Update Timeline for Definitive Agreement to Launch Collection of THC-infused Cannabis Products
Investorideas.com - Cannabis Stock News: Dixie Brands (CSE: DIXI.U) (OTC: DXBRF) and Herbal Enterprises Update Timeline for Definitive Agreement to Launch Collection of THC-infused Cannabis Products
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move: Rezwan Khan, President of Global Alliance for Cannabis Commerce Talks about SAFE Banking Act
Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move: Rezwan Khan, President of Global Alliance for Cannabis Commerce Talks about SAFE Banking Act
Rezwan Khan also Vice President of Global Corporate Development for DNA Genetics
Delta, Kelowna, BC –September 27 , 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/09271Interview-RezwanKhan-SAFEBankingAct.asp
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts
In today’s podcast I interview Rezwan Khan, President of the Global Alliance for Cannabis Commerce, where we discussed the recent voted in favor of the Secure and Fair Enforcement (SAFE) Banking Act U.S. through the House of Representatives, and the expectations surrounding this legislation moving forward.
Rezwan Khan, J.D. is also the Vice President of Global Corporate Development for DNA Genetics, the most recognizable and award-winning cannabis company in the world, and co-Founder of seedleSs, the first cannabis marketing firm, incubating many of the top brands in the industry. “Rez” is one of the most widely-respected voices within the world-wide cannabis community with decades of experience in the issues facing international and emerging cannabis marketplaces, and is a leading expert on national and international comparative cannabis law and regulatory compliance.
Rez discussed the recent passing of the SAFE Banking Act through the House saying, “The Safe Banking Act actually took a really interesting journey. Initially we were making sure to get support in the House and along the way we were gently reminded that the House might be preaching to the choir, but good luck with the Senate Republicans and even better luck with Mitch McConnel. The Republican Senators made it very clear to us that they were not going to be prepared to support this unless we included Choke Point language. The entire thing got really political. For people that aren’t familiar, there was an Obama Era {initiative called} Operation Choke Point, which effectively cut out off banking services to some industries that are federally legal. So the narrative then was that we’re not going to be able to support Safe Banking for cannabis, especially as a stand alone cannabis reform legislation, if we are not prepared to address safe banking for these other industries that are federally legal. The example they used was fireworks. On its face that argument makes a lot of sense, but the reality is it’s a political maneuver because its about undoing all things Obama at then end of the day, but we as an organization don't get political beyond the cannabis issue. That might stack our deck for getting through the Republican Senate, but then you still have Mitch McConnel.”
Operation Choke Point was a 2013 initiative of the United States Department of Justice, which investigated banks in the United States and the business they did with firearm dealers, payday lenders, and other companies believed to be at higher risk for fraud and money laundering.
Rez continued, “We were able to get some very valuable intel from Kentucky, that the Hemp farmers are starting to experience what us cannabis guys have experience for many years, which is all of a sudden there is a question as to the source of their funds, questions as to the specific lineage of plants that they’re growing and further it's almost impossible for lawmakers and regulators to differentiate CBD that’s derived from Hemp versus derived from Cannabis. The inability to make that distinction really puts all of the Hemp farmers in jeopardy. So we were able to really take that and re-present it to a few prominent Senate Republicans, and pose the question, ‘Because you can’t differentiate CBD derived from Cannabis versus CBD derived from Hemp, how can you allow the legacy of revitalizing American Agriculture through the Farm Bill to just crumble, when it’s a quick fix to add language to the Safe Banking Act?’”
Rez continued to discuss the balancing act necessary when dealing with Cannabis legislation between the activist/grass routes element of the cannabis industry and the reality of how bureaucratic legislation is passed as well as the real time frame expectations for the Safe Banking Act.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Investor Ideas adds New #Stocks in Mining (CSE: $IMCX.C) (TSXV: $HIGH.V), Cannabis (CSE: $WIKI.C, $BILZ.C, $BUZZ.C) & Crypto (CSE: $VYGR.C)
Investor Ideas adds New #Stocks in Mining (CSE: $IMCX.C) (TSXV: $HIGH.V), Cannabis (CSE: $WIKI.C, $BILZ.C, $BUZZ.C) & Crypto (CSE: $VYGR.C)
Point Roberts WA, Delta BC, September 27, 2019 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces this week’s additions to its global stock directories in mining, cannabis and crypto.
This week’s new mining companies are all recent listings on Canadian Exchanges (TSX Venture and CSE) with interest in the exploration of mineral properties, including gold.
The latest cannabis companies are all CSE-listed and are involved in business within Europe, Israel, the United Kingdom, Mexico, Canada and United States.
The newest crypto company, Voyager Digital (Canada) Ltd. (CSE:VYGR) is a crypto-asset broker.
New Mining Companies:
Yukoterre Resources Inc. (CSE:YT) is a natural resource company engaged in the acquisition and exploration of mineral properties.
Corsurex Resource Corp. (CSE:CRC) is a junior natural resource issuer specializing in gold exploration in Guyana.
IMC International Mining Corp. (CSE:IMCX) is a junior exploration and development company. It is focused on creating shareholder value through the acquisition, exploration and development of gold assets, which include the Company’s 100% owned Bullard Pass Property in Arizona.
HighGold Mining (TSXV: HIGH.V) is a mineral exploration company focused on premier high-grade gold projects located in North America. HighGold's flagship asset is the high-grade Johnson Tract Gold (Zn-Cu) Project located in south-central Alaska, USA, acquired as part of a lease agreement with CIRI, an Alaska Native regional corporation. The Company also controls an extensive portfolio of quality gold projects in the greater Timmins gold camp, Ontario, Canada that includes the Munro-Croesus Gold property, which is renowned for its exceptionally high-grade mineralization, and the large Golden Mile and Golden Perimeter properties. HighGold's experienced Board and senior management team, consisting of President, CEO and director Darwin Green, CFO and director Aris Morfopoulos, VP Exploration Ian Cunningham-Dunlop, and VP Investor Relations Naomi Nemeth, along with independent Board members Michael Gray, Michael Cinnamond and Dr. Lance Miller, are committed to providing shareholder value through discovery, careful stewardship of capital, and environmentally and socially responsible mineral exploration activities.
New Cannabis Companies:
Wikileaf Technologies Inc. (CSE: WIKI) is a price comparison platform for recreational and medicinal cannabis consumers. Wikileaf provides consumers with instant price comparison among dispensaries in their immediate vicinity. It is a portfolio company of Nesta Holding Co. Ltd. (“Nesta”), a private equity firm focused on the global cannabis industry. Nesta was founded in 2015 by Chuck Rifici, Chair of Auxly Cannabis Group and co-founder of Canopy Growth Corporation.
Ignite International Brands, Ltd. (CSE: BILZ; OTCQX: BILZF) is operating in permissible CBD and cannabis sectors. Ignite intends to expand its business, which currently includes branding, marketing, licensing, sales and distribution, across the United States, Canada and into international jurisdictions such as the United Kingdom and Mexico by leveraging multiple product platforms. The Company intends to effect this expansion through brand leverage, product development, targeted marketing and strategic supply chain partnerships in each of its active and target jurisdictions.
Aura Health (CSE:BUZZ) (OTC:LMLLF) is building a vertically-integrated cannabis business focused on Europe and Israel. The Company (i) owns 80% of Pharmadrug, a German medical cannabis distributor, with a Schedule I European Union narcotics license allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU, (ii) owns a convertible note convertible into 54% of the outstanding equity of HolyCanna Ltd., a cultivation and nursery license holder in Israel, and (iii) agreement to own 57% of CannabiSendak Ltd., the builder of a network of dispensaries in Israel. Additionally, through significant extraction IP, Aura is dedicated to building a high-margin, downstream business of end-user products.
New Blockchain Companies:
Voyager Digital (Canada) Ltd. (CSE:VYGR) is a crypto-asset broker that provides retail and institutional investors with a turnkey solution to trade crypto assets. Voyager offers customers best execution and safe custody on a wide choice of popular crypto-assets. Voyager seeks to bring a better, more transparent and cost-efficient alternative for trading crypto-assets to the marketplace.
The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media services at Investorideas.com
To sponsor a daily podcast for the month or to be an expert guest please contact us!
Contact Investorideas.com
800-665-0411
Thursday, September 26, 2019
Investorideas.com - House Members Pass Historic Legislation Legitimizing Retail Cannabis Sales
Investorideas.com - House Members Pass Historic Legislation Legitimizing Retail Cannabis Sales
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - Cannabis Stock News: Village Farms International (TSX: $VFF.TO) (NASDAQ: $VFF) Ranks Number Three of 30 Top-Performing Companies in Inaugural TSX30 Program
Investorideas.com - Cannabis Stock News: Village Farms International (TSX: $VFF.TO) (NASDAQ: $VFF) Ranks Number Three of 30 Top-Performing Companies in Inaugural TSX30 Program
www.investorideas.com - news that inspires big ideas
www.investorideas.com - news that inspires big ideas
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Safe Banking Act Passed- News from (CSE: $HARV.C) (TSX: $VFF.TO) (NASDAQ: $VFF) (TSX.V: $PURE.V) (NYSE: $CGC)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Safe Banking Act Passed- News from (CSE: $HARV.C) (TSX: $VFF.TO) (NASDAQ: $VFF) (TSX.V: $PURE.V) (NYSE: $CGC)
Delta, Kelowna, BC –September 26 , 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/09261HARV-VFF-PURE-CGC.asp
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts
In today’s podcast we look at a few early announcements.
But first, yesterday the U.S. House of Representatives voted in favor of the Secure and Fair Enforcement (SAFE) Banking Act, a landmark bill that would provide safe harbor and guidance to financial institutions that work with legal cannabis businesses. The historic vote was the first time that a standalone marijuana bill has come before the full House. The vote needed a two-thirds majority to pass and was supported by 321 votes in favor to 103 against.
For years, cannabis businesses have been hamstrung by their inability to access bank financing for acquisitions, operations and expansion. It has also forced the industry to operate largely in cash.
While the Democratic-controlled House of Representatives voted to pass the bill protecting banks that work with the marijuana industry, some analysts are still warning that the measure isn’t likely to become law in 2019 as it faces a tough road in the Republican-controlled Senate.
The chances of enactment this year for the bill — known as the Secure And Fair Enforcement (SAFE) Banking Act — have risen to 1 in 3, up from 1 in 5, reckons Ian Katz, an analyst at Capital Alpha Partners. Those still aren’t great odds, however. “We remain skeptical for now,” Katz said in a note before the House vote, though he added that the chances could get better “if we see meaningful signals from the Senate in the next few weeks.”
Many in the industry are also looking at the MORE Act as the next legislation to hopefully pass through the house. The Marijuana Opportunity Reinvestment and Expungement (MORE) Act would remove cannabis from the Controlled Substances Act and take steps to begin repairing the harms of the war on drugs. The bill is sponsored by House Judiciary Committee Chairman, Jerrold Nadler (D-NY), who has already signaled that he is committed to advancing it through the House.
Also, StrainprintR Technologies Ltd., the leader in cannabis data and analytics, announced the release of The Canadian Medical Cannabis Experience: A 2019 Patient Retrospective, the latest Strainprint research publication designed to support the entire cannabis industry with meaningful insights based on the technology leader's unique and broad-based patient-led data. The Report features thorough analysis of more than 800,000 real-time anonymous patient outcomes reported during the period from January to December 2018.
"We hear time and time again about the need for comprehensive resources like our Patient Retrospective Report," said Strainprint President, Dave Berg. "Medical cannabis hasn't had decades of clinical trials to form guidelines on dosing, onset and efficiency and with over 450 chemical constituents in every strain, it is not like studying single molecules in traditional pharma. So, real-world patient data is invaluable for medical professionals and industry stakeholders looking to make informed choices for their patients and businesses."
Strainprint aggregates anonymous patient-reported data from its award-winning mobile journaling App and through surveys and validated questionnaires from its online Strainprint Community. Strainprint has been collecting this unique and proprietary data since 2016 and it grows more granular by the day. Today, it is the largest data set of its kind in the world with more than 1.4 million sessions and 70 million data points on strain efficacy. It is the only cannabis consumption data tracked in real time against more than 1,600 lab-verified products by batch.
"Tracking symptomatic improvement against chemical profile (ingredients) by batch is the only way for the industry to advance the scientific understanding of cannabis," said Michelle Arbus, Strainprint VP of Research. "We are fortunate in Canada to have a federal program with very high lab testing requirements, consistent across the country, giving us the most standardardized products from which to study and the best chance at personalizing cannabis as a medicine."
The 2019 Patient Retrospective Report is the cutting edge of cannabis research and a major milestone for the cannabis industry. The Report analyzes user variables such as age, gender, region, usage frequency and efficacy by symptom and is the first research set able to identify which terpenes are active in the cannabis products that are reported to have the highest efficacy by symptom. A few key findings from the Report include:
● Muscle pain, anxiety, depression, joint pain and insomnia are the top five symptoms that patients treated with cannabis during the Report period;
● There are clear gender differences for the preferred choice of cannabis administration and the most effective methods of can vary by region, gender and age;
● Multiple cannabis species are reported to offer comparable relief for particular symptoms, supporting the hypothesis that it is more than the species or the THC:CBD content that determines efficacy of a strain;
● Patients overwhelmingly report positive and or neutral emotive effects from their medical cannabis use with very few unfavorable side effects. As well, the specific terpene profiles present in a strain can greatly impact the side effects; and
● There was no significant change in how or when patients treated their various symptoms after cannabis was legalized recreationally in Canada.
●
While more study is certainly needed, Strainprint has raised the bar for cannabis industry research with the largest and most granular real-world observational patient study available. Strainprint Reports complement this data with actionable insights and are available for purchase at https://strainprint.ca/strainprint-reports/.
As well, Investorideas recently interviewed Andrew Muroff the CEO of Strainrpint at the ICBC Conference in Vancouver, regarding the company's recent reports. To listen click here.
Harvest Health & Recreation, Inc. (CSE: HARV) (OTCQX: HRVSF) today announced an exclusive partnership with Last Prisoner Project ("LPP"), a new non-profit organization committed to making sure that every cannabis prisoner is released, welcomed home and supported by their community. Harvest is the first large cannabis company to create a proprietary program focused on job creation for formerly incarcerated prisoners that have been affected by the criminalization of cannabis. Harvest and LPP's "Prison to Prosperity" pipeline of talent will focus on facilitating re-entry of individuals impacted by the war on drugs back into society, through workshop training programs, with the goal of providing employment opportunities at Harvest locations nationwide.
According to the US Department of Justice Bureau of Justice Statistics, within three years of release over two-thirds of released prisoners are re-arrested, and within six years of release that number jumps to 79%. The "Prison to Prosperity" program is designed to reverse this statistic and demonstrates Harvest's continued commitment to social justice, diversity and inclusion. It is designed to bring restorative justice to communities most affected, while bringing positive economic impacts to the residents and communities that the company serves.
"Over 40,000 prisoners in the U.S. are currently serving sentences for cannabis charges. While many companies are focused on decriminalization, expungement and clemency, Harvest recognized that re-entry can be incredibly difficult without help," said Harvest Chief Executive Officer Steve White. "We've partnered with the Last Prisoner Project to provide training courses, workshops and funding to help individuals re-enter the job marketplace, with the hope of ultimately placing them in employment opportunities within our Harvest network."
"I launched the Last Prisoner Project out of the conviction that it is wrong to continue to punish people for something society has decided should no longer be illegal, and in the belief that if I asked the legal cannabis industry to contribute the funds needed to gain the release of our prisoners, cannabis companies would see it as an opportunity to do the right thing, to put the values cannabis teaches into action," said Steve DeAngelo, Founder of Last Prisoner Project. "I am pleased and heartened by the response so far from cannabis companies and by many world-renowned musicians, including Stephen and Damian Marley, Willie Nelson, and Eric Rachmany. This overwhelmingly positive response gives me high hopes and strong confidence that the day will come when the last cannabis prisoner on Planet Earth is free to come home to their families. Until then, our mission continues."
Harvest's "Prison to Prosperity" program will offer vocational training opportunities and educational programs specific to the cannabis industry for those who continue to be disadvantaged by a criminal record. The program will begin with a pilot project working in tandem with local reentry organizations in California and will roll out nationally at a later date.
Pure Global Cannabis Inc. (TSX.V: PURE) (OTC: PRCNF) announced the creation of a new business unit, PureCanna Solutions. This B2B brand will provide white label extraction, co-processing, co-manufacturing, tolling, and cannabis and CBD isolate and extract bulk sales.
PureCanna has already entered into negotiations with potential clients and suppliers to provide immediate access to the Company's extensive line of products and manufacturing techniques, which include packaging for dried flower, oils bottles, vape pens, and capsules. As the Company continues to upscale their manufacturing and processing capabilities, the creation of this new division will offer significant revenue generating potential with exceptional margins.
Pure Global CEO & President, Malay Panchal said, "This new division will allow us to quickly and substantially increase high margin sales by servicing industry partners who share the same vision of creating only the highest quality products. Adding CBD bulk sales, white label, and co-processing services leverages our existing capabilities and any underutilized capacity."
In preparation for this development, the Company submitted their readiness packages in early August for Health Canada approvals of Phase 2 of their Brampton facility expansion, which upon approvals will immediately allow for cultivation along with manufacturing capabilities of 20 to 30kg of cannabis extract for bulk sale via CO2 supercritical extraction. PureSinse is in the process of adding significantly more extraction capacity for hemp biomass processing in place of previously denominated cultivation rooms with target capacities of 100 to 200 tons annually and expected readiness in early H1 2020.
This represents the latest in a series of transformational announcements from Pure Global. The Company announced earlier this week the signing of a joint operating agreement with KMT-Hansa Corp. to cultivate, grow and process hemp and CBD products in China. In addition, Pure was recently granted their oil sales license from Health Canada.
Mr. Panchal continued, "PureCanna is set to become a leading provider of GMP and pharmaceutical grade CBD and cannabinoid isolates, ready to use formulations, co-manufacturing, and co-packaging services for CPG companies and LPs. I am very proud of the hard work that has gone into the development of this unit and look forward to forging new partnerships with some highly respected cannabis and CPG companies in Canada and globally."
Village Farms International, Inc. (TSX: VFF) (NASDAQ: VFF) today announced that it has ranked as the third top-performing company in Toronto Stock Exchange's (TSX) inaugural TSX30, a flagship program recognizing the 30 top-performing TSX stocks over a three-year period based on dividend-adjusted share price appreciation.
"Since Village Farms first publicly listed its shares in 2006, Toronto Stock Exchange has been an outstanding platform for investors to participate in the growth of our Company to one of the largest vertically integrated greenhouse growing operations in North America," said Michael DeGiglio, CEO and Founder, Village Farms International. "Now, leveraging more than three decades as a leader in large-scale, precision agriculture, we are adding to our legacy produce business with the biggest opportunity in our history as we pursue outsized, long-term growth potential in the cannabis and CBD markets."
"Although this award recognizes outstanding recent performance, Village Farms is only just beginning to realize the value of these significant new growth opportunities, which have transformed both our near- and long-term earnings potential, and which we expect will drive growth for years to come. Our financial results are just starting to benefit from the success of our 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production in Canada, Pure Sunfarms, which is already one of the most profitable companies in the industry. Moreover, financial performance in the coming quarters should reflect Pure Sunfarms recent ramp to full capacity at its first greenhouse, the planned doubling of capacity next year with the conversion of a second greenhouse, and the potential to more than double that capacity again through the option to add a third greenhouse."
"In parallel, in the United States we are aggressively pursuing the significant opportunity in hemp and CBD. We expect to generate our first hemp biomass sales later this year, and then rapidly transition into higher margin CBD crude oil and then our own CBD products, as we build a leading consumer packaged goods company in this exciting, high-growth market. All of this should drive even further value for our shareholders over both the short and long terms."
"We are extremely proud to present the TSX30, a new recognition program featuring some of the most compelling success stories among our listed issuers, including companies operating in traditional areas of strength like natural resources and also in newly defined sectors like clean tech and cannabis," said Loui Anastasopoulos, President, Capital Formation, TMX Group. "TSX listed companies play a vital role in Canada's capital markets and as we continue to evolve into a global leader, TSX remains committed to our work in support of this crucial ecosystem. Today, we congratulate the companies included in the inaugural TSX30 for all of their achievements and look forward to continuing to serve them along each stage of their growth path into the future."
Spectrum Therapeutics, the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announced a donation to the Fondation de l'Hôpital du Sacré-Coeur de Montreal (Montreal Sacre Coeur Hospital Foundation) to support the Canadian Sleep and Circadian Network's ("CSCN") associated national campaign: Sleep On It which aims to raise awareness about the importance of good quality sleep on health.
Spectrum's donation to the campaign has been made, based on CSCN's request to support their initiative to organize the sleep scientific community around the question of cannabis use for sleep disorders. Although an increasing volume of anecdotal data indicates the growing usage of cannabis from individuals coping with sleep disorders, clinical scientific evidence on its effectiveness is still limited. Hence, via this donation, CSCN will be able to provide to the public, health management decision makers as well as the sleep scientific community, a review of currently available data and identify the research gaps that need to be filled. This review is expected to be completed during the second half of the 2020 calendar year.
By partnering with the leader in the cannabis industry, CSCN's objective is to combine the expertise of clinicians, physicians and researchers across the country to facilitate and scientifically support the development of a white paper based on a comprehensive review of all existing literature and facts about the use of cannabis in sleep disorder management. The report is also expected to be published during the second half of the 2020 calendar year and will introduce an updated clinical research program looking at all areas that impact quality of sleep, including pain, aging, and sleep disorders such as insomnia. Ultimately, the white paper will provide insights and guidance on future research directions and further requirements for evidence on the potential application of medical cannabis in treating sleep disorders.
"Good quality sleep is far more important to our long-term health than most people realize," commented Dr. Mark Ware, Chief Medical Officer, Canopy Growth. "We're just now beginning to explore the role cannabis can play in addressing sleep-related disorders. Patient feedback is very promising so far, and partnerships such as these will advance our understanding of the intriguing phenomenon of sleep that is so essential to our overall well-being."
"The legalization of cannabis in Canada has brought about a natural interest in the potential for cannabis in the treatment of sleeping disorders. We need to catalyze the development of collective efforts to further develop scientific knowledge platforms to inform policy, therapeutic practice, and prevention efforts about sleep and cannabis and to scientifically inform decision makers as well as the general public about the research needs to produce evidence based data on sleep and cannabis," commented Dr Julie Carrier, Scientific Director of the Canadian Sleep & Circadian Network and sleep researcher at the CIUSSS du Nord-de-l'Île-de-Montreal.
One in three Canadians don't get the recommended seven hours of sleep each night. The CSCN's mission is to mobilize the healthcare community to adopt an integrated approach towards improving outcomes and treatment of patients with sleep disorders.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Subscribe to:
Posts (Atom)